November 30, 2024Journal of Student ResearchOpen Access

Epigenetic Modifications: A Therapeutic Approach in Alzheimer's Disease

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis reveals potential of epigenetic therapies to reverse cognitive deficits in Alzheimer's patients, suggesting a shift in treatment goals.

Epigenetic therapies may reverse cognitive deficits in Alzheimer's disease, highlighting new treatment pathways.
Multiple pre-clinical trials support the efficacy of epigenetic modifications in managing Alzheimer's progression.
Assessment through a comprehensive literature review showcases the promise of therapies like HDAC inhibitors and RNA-based treatments.
This research emphasizes the need for human clinical trials to validate these therapies as viable options for Alzheimer's care.

Santhosh et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Analysis reveals potential of epigenetic therapies to reverse cognitive deficits in Alzheimer's patients, suggesting a shift in treatment goals.